A Biodistribution Study of the Radiolabeled Kv1.3-Blocking Peptide DOTA-HsTX1[R14A] Demonstrates Brain Uptake in a Mouse Model of Neuroinflammation.
HsTX1[R14A]
Kv1.3 channels
microglia
neuroinflammation
positron emission tomography (PET)
Journal
Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791
Informations de publication
Date de publication:
02 01 2023
02 01 2023
Historique:
pubmed:
5
11
2022
medline:
4
1
2023
entrez:
4
11
2022
Statut:
ppublish
Résumé
The voltage-gated potassium channel Kv1.3 regulates the pro-inflammatory function of microglia and is highly expressed in the post-mortem brains of individuals with Alzheimer's and Parkinson's diseases. HsTX1[R14A] is a selective and potent peptide inhibitor of the Kv1.3 channel (IC
Identifiants
pubmed: 36331024
doi: 10.1021/acs.molpharmaceut.2c00614
doi:
Substances chimiques
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
1HTE449DGZ
Lipopolysaccharides
0
Gallium Radioisotopes
0
Peptides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM